AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06736444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Alcohol Screening and Intervention for College Students (BASICS)
Description: Brief Alcohol Screening and Intervention for College Students (BASICS) is a manualized brief intervention targeting alcohol use and consequences among high risk drinkers and includes both personalized feedback regarding drinking norms, consequences, and motives for drinking, as well as protective behavioral skills for reducing heavy episodic drinking and related consequences. BASICS is delivered in a motivational interviewing (MI) style (Miller \& Rollnick, 2002) to enhance intrinsic motivation to change drinking and implement protective behavioral strategies. BASICS has been adapted to target marijuana use and has been adapted for use with a variety of populations.
Study NCT06736444 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Attention Control
Description: Attention Control is comprised of 4 weekly 20-minute check-ins with a study therapists regarding the daily monitoring and mood/functioning. Referrals for additional services will be provided as needed.
Study NCT06735521 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance stress-perfusion
Description: Included patients will be examined at the Karolinska University Hospital in a 1.5T Siemens Sola magnetic resonance camera at rest and during adenosine stress with specific CMR sequences (adenosine stress-perfusion, myocardial velocities, and tissue characterization) for non-invasive determination of macro- and microvascular dysfunction, global myocardial function, pulmonary artery pressure and scarring of the myocardium.~Adenosine or Regadenoson will be used as stress medication which is according to clinical routine. Adenosine will be infused over approximately 5 minutes (110-140 μg / kg/min), Regadenoson (5 ml) will be a 10-second injection (400 μg single dosage). Intravenous gadolinium-based contrast agents will be administered, Gadovist (1 mmol/ml, gadobuterol), 0.15 mmol/kg during stress and rest.
Study NCT06473974 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Test cosmetic product
Description: Test cosmetic product: Test cosmetic product will be applied to affected hyperpigmented areas twice daily at AM and PM.~Cleanser and sunscreen: A facial cleanser will be used twice daily (morning and evening) by gently rubbing it on face and neck, then rinse and pat dry. Sunscreen of SPF 50, apply evenly on face and neck, 20 minutes before stepping out.
Study NCT05370612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dexcom G6 CGM
Description: Dexcom 6 CGM, an FDA approved device. Sensors will be placed on the abdomen per package instruction to collect continuous glucose data.~Experimental Group will wear CGM for the duration of their pregnancy.~Control Group will have CGM data collected for 10 days at enrollment and at 28-32 weeks into their pregnancy.
Study NCT05370612 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dexcom G6 CGM
Description: Dexcom 6 CGM, an FDA approved device. Sensors will be placed on the abdomen per package instruction to collect continuous glucose data.~Experimental Group will wear CGM for the duration of their pregnancy.~Control Group will have CGM data collected for 10 days at enrollment and at 28-32 weeks into their pregnancy.
Study NCT05370612 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Participant Finger Stick Glucose Monitoring
Description: Standard of care for individual participant
Study NCT05102084 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Listening to music with a bluetooth headset to patients receiving CPAP support
Description: Listening to music with a bluetooth headset during the CPAP application to the patients and checking the compatibility on the CPAP device.
Study NCT05377190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuum HFC-IN
Description: Combination of a mobile application (with remote monitoring) and digital therapeutics
Study NCT05377190 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care for the follow-up
Description: No mobile application or digital therapeutics are used
Study NCT05377190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuum HFC-OUT
Description: Combination of a mobile application (without remote monitoring) and digital therapeutics
Study NCT04564963 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: Application of cryotherapy (e.g. ice in resealable zipper storage bags, gel packs, ice packs) over largest closed incision in the post-operative period every 4 hours, at minimum, for up to 72 hours (while participant is awake and admitted to hospital). The cryotherapy should not be placed in direct contact with skin.
Study NCT05510765 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transportation service
Description: Improved transportation assets applied to all aspects of subjects life
Study NCT05570942 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oral Lactobacillus rhamnosus TCELL-1
Description: A kind of probiotics which was isolated from the intestinal mucosa of health Taiwanese people
Study NCT05570942 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral Lactobacillus rhamnosus TCELL-1
Description: A kind of probiotics which was isolated from the intestinal mucosa of health Taiwanese people
Study NCT04824638 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 3 doses of BNT162b2 vaccine
Description: Administration of BNT162 b2 vaccine (30µg in 0.3mL) at D1 D29 and M8, intramuscularly (participants without antecedent of SARS-CoV-2 infection)
Study NCT04824638 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 2 dose of BNT162b2 vaccine
Description: Administration of BNT162 b2 vaccine (30µg in 0.3mL) at D1 and M8, intramuscularly (participants with antecedent of SARS-CoV-2 infection)
Study NCT05048953 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Muscle ultrasound measurements (the index test)
Description: The following parameters will be measured by muscle ultrasound~1. Muscle thickness~2. Muscle echogenicity~3. Muscle fasciculations
Study NCT06359366 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: perineal massage combined hip joint training
Description: pregnant women take the lithotomy position, disinfect the vulva, and wear sterile gloves. Then thumbs, forefingers, and middle fingers dip massage oil to do a 2 minutes pressurized dilatation massage from inside to outside gently to loosen the fascia. Then rest 30s. All steps need to be repeated 2 to 3 times. When the pregnant women feel a slight sense of acidity and tingling sensation disappears, researchers sterilize the perineal body again. left side pelvic floor receives the same intervention as right. The whole process takes 15-20min, 5 times a week until delivery. Additionally, while using the pelvic floor fascia manipulation, pregnant women are instructed to perform specific movements of internal and external hip rotation, adduction and abduction, upward and downward.
Study NCT06472154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: The experimental group intervened based on the midnight-noon ebb-flow theory, listening to music corresponding to the five organs at different time periods.
Study NCT06472154 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: The control group listened to Chinese five elements music pieces from 13:00 to 18:00 p.m., each music piece for within 30 minutes for, 5 days per week, 4 weeks for a cycle, 3 cycles in total.
Study NCT05317247 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cough sounds
Description: The investigators will discover a cough audio signature and then validate it.
Study NCT05315362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: solid microneedle skin patch
Description: intradermal vaccination with a skin patch
Study NCT05315362 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: mRNA-1273
Description: administration of mRNA-1273 vaccine
Study NCT05315362 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Description: administration of mRNA-1273 vaccine
Study NCT05315362 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: standard needle
Description: intramuscular vaccination with a standard needle
Study NCT06157957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Lung cancer screening with low dose CT scan
Description: Low dose CT scan in active smokers or ex-smokers with an age between 50 and 75 years old
Study NCT06495528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pain management with BLISS DTx
Description: Bliss DTx is a Digital Therapeutics (DTx) which uses virtual reality augmented with sound and visual stimuli to reduce pain during Port-A-Cath setting
Study NCT06495528 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pain Management with site standard of care sedation protocol
Description: Sedation (morphine and/or hypnotics and/or anxiolytics and/or conversational hypnosis) reduces pain during Port-A-Cath setting
Study NCT05895604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership
Description: Nurse-Family Partnership is a prenatal and infancy home visiting program providing regular visits to first-time mothers until the child is two years old
Study NCT05030454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ETHOS
Description: Ring-gantry CT-guided radiotherapy unit, pairing a linear accelerator within a ring-gantry imaging unit.
Study NCT05030454 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CT-guided stereotactic adaptive radiotherapy
Description: All participants will be initially planned to at least 35 Gy in 5 fractions, subject to hard constraints based on the treatment site.
Study NCT06401564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Therapy
Description: Each participant will receive one or two 20 minute VR sessions during their admission. Participants are able to pause or discontinue at any time. During each VR session, participants will use the REAL Immersive VR system and be equipped with a VR headset and 6 sensors attached to the torso, waist, and upper extremities. Patient will then undergo various virtual challenges guided by the physical or occupational therapist facilitating movements of the upper extremity, core, head, and neck.
Study NCT06417320 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACEI, SGLT-2i
Description: Group 1 (ACEI group) will receive a single dose of oral ACE inhibitors tablets per day (0.2-0.6mg) /kg/ day)~❖ Group 2 (combined ACEI and SGLT-2inhibitrs group) patients on a single dose of oral ACE inhibitors tablets per day (0.2-0.6mg /kg/ day) presenting with persistent nephrotic range proteinuria will add a single dose of oral SGLT-2 inhibitors tablets 5mg per day (weight≤30kg) or 10mg per day (weight >30kg)
Study NCT05378841 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Denervation
Description: This is an outpatient procedure performed under local anesthesia (depending on the anesthesiologist's decision), which lasts about 30 minutes.
Study NCT01161602 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pumosetrag
Study NCT01161602 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05526742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-510 capsule (reference)
Description: Single-dose of CKD-510 will be administered as oral capsule in a fasted state.
Study NCT05526742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-510 tablet (test)
Description: Single-dose of CKD-510 will be administered as oral tablet in a fasted state.
Study NCT05526742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-510 tablet (test)
Description: Single-dose of CKD-510 will be administered as oral tablet in a fed state.
Study NCT05078619 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No PCI
Description: Omission of PCI of significant coronary artery disease prior to TAVI
Study NCT06438848 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy program
Description: group will be prescribed a usual physical therapy program three times a week for four weeks, which will be conducted in the clinic. The program consists of eight sessions comprising warm-up and cool-down, stretching activities, and strengthening exercises, and manual therapy. The program will start with 10-minute warm-up and 10-minute cool-down periods of physical therapy sessions
Study NCT06438848 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy program with lymphedema drainage
Description: physical therapy program three times a week for four weeks, which will be conducted in the clinic. The program consists of eight sessions comprising warm-up and cool-down, stretching activities, and strengthening exercises,And manual lymphatic drainage prescribed 20 minutes of MLD daily. The program will be prescribed five times a week, for four weeks
Study NCT06489639 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DOCT-SAD
Description: Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder is a 10-session, combined individual/group clinical intervention for treating social anxiety in adolescents. It consists of four individual and six group sessions during ten weeks. DOCT-SAD groups are formed for 4-6 adolescnts. One parent or both parents attend two of the individual sessions.
Study NCT06489639 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SC
Description: Standard Counseling (SC) is a intervention consisting of counseling sessions delivered by a school health and welfare (SHWS) professional (i.e., school nurse, school social worker, or school psychologist) to support a student with social anxiety. The defined length of intervention is ten weeks, and number of sessions will be according to what is routinely agreed between the professional and the adolescent. In SC, routine professional working methods and procedures available to the SHWS professional delivering the intervention are used.
Study NCT05316532 — intervention group
Intervention type: DEVICE
Intervention: Prismalung + treatment
Description: Low-flow extracorporeal CO2 removal with or without concurrent continuous renal replacement therapy
Study NCT05030103 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Reading glasses, +2.0 diopters
Description: The participants in the glasses-group are asked to wear the reading glasses during near-work.
Study NCT05097729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: The brain stimulation can be delivery using different devices; in this project a MagPro X100 stimulator connected to a MagPro Cool-B65 liquid-cooled butterfly coil (MagVenture A/S, Farum, Denmark) will be used. Resting motor threshold (M1-rTMS) will be determined during the visit 1 or visit 2 and used along all visits. The rTMS pulse sequences and intensities used are all within the published safety guidelines
Study NCT05097729 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: The brain stimulation can be delivery using different devices; in this project a MagPro X100 stimulator connected to a MagPro Cool-B65 liquid-cooled butterfly coil (MagVenture A/S, Farum, Denmark) will be used. Resting motor threshold (M1-rTMS) will be determined during the visit 1 or visit 2 and used along all visits. The rTMS pulse sequences and intensities used are all within the published safety guidelines
Study NCT05097729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: The brain stimulation can be delivery using different devices; in this project a MagPro X100 stimulator connected to a MagPro Cool-B65 liquid-cooled butterfly coil (MagVenture A/S, Farum, Denmark) will be used. Resting motor threshold (M1-rTMS) will be determined during the visit 1 or visit 2 and used along all visits. The rTMS pulse sequences and intensities used are all within the published safety guidelines
Study NCT06007365 — intervention group
Intervention type: DEVICE
Intervention: Z5m Dental Implants
Description: This is an observational study, collecting data on the use of Z5m Dental Implants.
Study NCT04973020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6390、efavirenz
Description: SHR6390 tablet single dose；Efavirenz single dose.
Study NCT04825171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bryophyllum 50 % Chewing Tablets
Description: Each 350 mg tablet corresponds to 170 mg of leave press juice from Bryophyllum pinnatum, dried down to 17 mg by mixing with lactose; 100 mg dried BP matter in 1 g.
Study NCT06321289 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic CD19-STAR T cell
Description: Phase 1 dose escalation (3+3): dose 1 (2×10\^6 cells/kg), dose 2 (6×10\^6 cells/kg), dose 3 (1.8×10\^7 cells/kg); Phase 2: dose of RP2D. No more than 5 × 10\^4 per kilogram of allogenic residual TCR-positive T cells harbouring in grafts can only be released for recipient infusion.
Study NCT06321289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Intravenous fludarabine 30-50 mg/m\^2/day on days -5, -4, and -3.
Study NCT06321289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 500-1000 mg/m\^2/day on days -5, -4, and -3.
Study NCT04700527 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Short Chain Fatty Acid
Description: Participants will take the supplement as prescribed to determine if it can help with GI toxicity
Study NCT04700527 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tapioca Flour
Description: Participants taking this will be used as a control group compared to those receiving the SCFA supplement
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-548
Description: Tablets for oral administration.
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HB/APAP
Description: Capsules for oral administration.
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (matched to VX-548)
Description: Placebo matched to VX-548 for oral administration.
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (matched to VX-548)
Description: Placebo matched to VX-548 for oral administration.
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (matched to HB/APAP)
Description: Placebo matched to HB/APAP for oral administration.
Study NCT05553366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (matched to HB/APAP)
Description: Placebo matched to HB/APAP for oral administration.
Study NCT04925986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitravatinib
Description: Groups 1A and 2A receive Sitravatinib 100mg orally (PO) daily starting on cycle 1 day 1 (C1D1). Groups 1B and 2B) receive Sitravatinib 100mg orally (PO) daily starting on Cycle 2 Day 1 (C2D1).
Study NCT04925986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: All groups (1A, 1B, 2A, 2B) receive Pembrolizumab 200mg intravenous every three weeks (IV Q3w) on cycle 1 day 1 (C1D1).
Study NCT06321926 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ActiveWaiting App
Description: The final prototype aims at increasing physical activity during the day by providing exercises for waiting periods and other idle time periods. The user can choose from a pool of exercises from five different categories (11 exercises for endurance, 65 exercises for strength, 67 exercises for flexibility, 11 exercises for relaxation, or 5 exercises for balance). Additionally, within each category, the user can choose only discrete exercises which are not noticeable to an observer. If the user has used the app before, the last or previously saved settings can be chosen. Every input field has an information icon showing a short description of the input field.
Study NCT06321926 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ActiveWaiting App
Description: The final prototype aims at increasing physical activity during the day by providing exercises for waiting periods and other idle time periods. The user can choose from a pool of exercises from five different categories (11 exercises for endurance, 65 exercises for strength, 67 exercises for flexibility, 11 exercises for relaxation, or 5 exercises for balance). Additionally, within each category, the user can choose only discrete exercises which are not noticeable to an observer. If the user has used the app before, the last or previously saved settings can be chosen. Every input field has an information icon showing a short description of the input field.
Study NCT04731038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib, Toripalimab, Paclitaxel, Cisplatin/ Carboplatin
Description: This is a single-arm study with all patients receiving these four drugs.
Study NCT06232512 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Haptic Device
Description: Provides sensory substitution by mapping pressure from the insole sensor onto a corresponding vibrating and heating patch to be worn where more sensation is present.
Study NCT05394220 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 16S rRNA gene amplicon sequencing
Description: molecular sequencing for the microbiome in parapneumonic effusion
Study NCT05514704 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Therapy via video conference
Description: The intervention will include the different levels of the following exercises that are given to the patient considering their functional level:~1. Straight leg raise (Level 1-2-3)~2. Quadriceps strengthening (Level 1-2-3)~3. Hip abductor/adductor strengthening (Level 1-2-3)~4. Hamstring stretch~5. Gastrocnemius stretch